Daejeon, South Korea

Cheol-Hee Kim

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.5

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cheol-Hee Kim

Introduction

Cheol-Hee Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in cancer research. With a total of 2 patents, his work focuses on developing pharmaceutical compositions for cancer prevention and treatment.

Latest Patents

One of his latest patents is a composition for enhancing TRAIL sensitivity, which includes inhibitors for the expression or activity of TIP41 as a target gene of TRAIL sensitizer. This invention relates to a pharmaceutical composition that can prevent and treat cancer. The research demonstrates that when liver cancer cell lines resistant to TRAIL are treated with TIP41 siRNA and TRAIL, apoptosis is induced in the cancer cells. Similar effects have been observed in lung and colon cancer cells that also exhibit resistance to TRAIL. Furthermore, the induction of apoptosis by TIP41 siRNA and TRAIL has been confirmed in tumor xenografts, leading to a reduction in tumor size. The MKK7/JNK pathway has been identified as a mediator of the apoptosis induced by this treatment, providing strong evidence that the pharmaceutical composition can be utilized for cancer prevention and treatment.

Another significant patent involves the gastric carcinoma gene ZNF312b, which serves as a diagnostic marker for stomach cancer. This invention includes a diagnostic method for stomach cancer and a screening method for stomach cancer inducers or inhibitors. The expression of the ZNF312b gene is specifically increased in stomach cancer, and its regulation affects cell proliferation and tumor formation. This marker gene can be effectively used for diagnosing stomach cancer, constructing animal models, and developing specific anticancer agents.

Career Highlights

Cheol-Hee Kim has worked with notable organizations such as the Korea Research Institute of Bioscience and Biotechnology and Neuromind Co., Ltd. His experience in these institutions has contributed to his expertise in biotechnology and cancer research.

Collaborations

Throughout his career, Cheol-Hee Kim has collaborated with esteemed colleagues, including Nam-Soon Kim and In-Sung Song. These collaborations have further enhanced his research and innovation in the field.

Conclusion

Cheol-Hee Kim's innovative contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His work not only provides insights into cancer treatment but also paves the way for future research in biotechnology

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…